FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications

Live updates

1. 2h ago

   FDA orders NAION blindness warnings on GLP-1 labels

   The U.S. Food and Drug Administration has ordered makers of GLP-1 drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, to add label warnings about nonarteritic anterior ischemic optic neuropathy, a rare condition linked to sudden vision loss and potential permanent blindness. The agency acted after reviewing reports connecting the popular diabetes and weight-loss medications to the optic nerve disorder. No specific case counts were provided in the available material. Patients should consult doctors before stopping treatment.

   Why it matters

   GLP-1 medications are widely prescribed for type 2 diabetes and obesity and have seen rapid adoption in recent years. NAION occurs when blood flow to the optic nerve is reduced, causing rapid, often painless vision loss in one or both eyes. The condition is considered rare, and the FDA has not established how frequently it occurs among GLP-1 users relative to the general population.

   What is confirmed

   • The FDA ordered manufacturers of Ozempic, Wegovy, Zepbound and Mounjaro to add warnings about nonarteritic anterior ischemic optic neuropathy to drug labels.
   • NAION is a rare eye condition that can cause sudden vision loss and may lead to permanent blindness.
   • The warning applies to GLP-1 drugs used for both diabetes and weight loss.

   Still unconfirmed

   • Specific numbers of blindness cases linked to GLP-1 drugs were cited by regulators.
   • The FDA advised patients to stop taking GLP-1 medications immediately.

   What to watch next

   • Manufacturer label updates and FDA communications on implementation timing
   • Further data on NAION incidence among GLP-1 users versus non-users
   • Clinical guidance for patients currently using GLP-1 drugs who experience vision changes
   Sources used for this update (21)

   1. www.sciencetimes.com — Sciencetimes
   2. nypost.com — New York Post – Breaking News, Top Headlines, Photos & Videos
   3. www.theguardian.com — AI godfather Geoffrey Hinton: ‘We’re creating alien beings. I’m willing to be selfish and choose humans’ | Donald Trump
   4. www.ynetnews.com — Great Britain
   5. CNN — US FDA orders new eye risk warnings for Ozempic, Zepbound
   6. NBC News — FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
   7. www.inquisitr.com — Shrapnel damages Saudi Aramco building in Riyadh
   8. The Washington Post — FDA tells GLP-1 makers to warn of potential vision loss side effect
   9. CBS News — GLP-1 drugs, popular for weight loss, get FDA warning of rare vision-loss side effect
   10. WSJ — U.S. Regulators Warn GLP-1 Drugs Carry Possible Rare Blindness Risk
   11. CNBC — FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
   12. Fox Business — FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
   confidence 50%